Published in Psychopharmacology (Berl) on January 01, 1983
A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs. Clin Pharmacol Ther (2010) 2.74
PHARM--an interactive graphic program for individual and population pharmacokinetic parameter estimation. Comput Biol Med (1984) 2.09
IGPHARM: interactive graphic package for pharmacokinetic analysis. Comput Biomed Res (1978) 1.71
Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline. Br J Clin Pharmacol (1975) 1.63
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy. Monaldi Arch Chest Dis (2005) 1.61
Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigens. Nature (1975) 1.60
A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics. J Biopharm Stat (1995) 1.54
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol (1998) 1.51
Cross validation of the factor structure of the 20-item Toronto Alexithymia Scale: an Italian multicenter study. J Psychosom Res (1996) 1.49
Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depression. Clin Pharmacol Ther (2012) 1.41
[Circulatory assistance in high-risk coronary angioplasty]. G Ital Cardiol (1990) 1.39
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet (1976) 1.25
Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology (1998) 1.14
Influence of age on mianserin pharmacokinetics. Psychopharmacology (Berl) (1982) 1.13
Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits. Eur J Pharmacol (1978) 1.13
Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease? Chest (1999) 1.05
[Multinational validation of the Composite International Diagnostic Interview (CIDI)]. Minerva Psichiatr (1994) 1.03
Traditional Chinese acupuncture in tension-type headache: a controlled study. Pain (1992) 1.02
Interactions between transcranial direct current stimulation (tDCS) and pharmacological interventions in the Major Depressive Episode: findings from a naturalistic study. Eur Psychiatry (2012) 1.02
Medically unexplained somatic symptoms in different cultures. A preliminary report from phase I of the World Health Organization International Study of Somatoform Disorders. Psychother Psychosom (1995) 0.99
Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies. Int J Cancer (1975) 0.99
Adaptive-optimal design in PET occupancy studies. Clin Pharmacol Ther (2010) 0.96
In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study. Neuroimage (2002) 0.96
Long-term treatment with mianserin: a clinical study with plasma levels. Adv Biochem Psychopharmacol (1982) 0.95
Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial. Int J Clin Pharmacol Res (1989) 0.95
The Senning operation for transposition of the great arteries. J Thorac Cardiovasc Surg (1978) 0.94
Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa. Antimicrob Agents Chemother (1991) 0.93
Transcranial direct current stimulation for the outpatient treatment of poor-responder depressed patients. Eur Psychiatry (2011) 0.93
Expressed emotion and schizophrenia in Italy. A study of an urban population. Br J Psychiatry (1992) 0.93
Cross-sectional echocardiographic study of criss-cross hearts and superoinferior ventricles. Am J Cardiol (1987) 0.93
Plasma concentrations, information and therapy adherence during long-term treatment with antidepressants. Br J Clin Pharmacol (1985) 0.92
Time-course analysis of the cardiovascular effects of clonidine resulting from the activation of cardiac pre- and vascular postsynaptic alpha-adrenoceptors in the pithed rat [proceedings]. Br J Pharmacol (1978) 0.92
Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats. J Pharmacol Exp Ther (1987) 0.89
Conventional vs controlled-release carbamazepine: a multicentre, double-blind, cross-over study. Acta Neurol Scand (1990) 0.89
Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) in patients with cirrhosis. Anesthesiology (1985) 0.89
A day at the European Respiratory Society Congress: passive smoking influences both outdoor and indoor air quality. Eur Respir J (2006) 0.88
A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia. Eur J Clin Pharmacol (1981) 0.87
Sulpiride pharmacokinetics in humans after intramuscular administration at three dose levels. J Pharm Sci (1984) 0.87
Biochemical characterization of alien H-2 antigens expressed on a methylcholanthrene-induced tumor. Proc Natl Acad Sci U S A (1979) 0.87
Second-hand smoke exposure in a sample of European hospitals. Eur Respir J (2009) 0.87
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. Psychiatry Res (1997) 0.87
A risk-benefit assessment of sulpiride in the treatment of schizophrenia. Drug Saf (1996) 0.86
Haemato-oncology and burnout: an Italian survey. Br J Cancer (2008) 0.85
Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer. Clin Cancer Res (2000) 0.85
Qualitative MRI findings in patients with schizophrenia: a controlled study. Psychiatry Res (2000) 0.85
Pharmacokinetics of propranolol in normal healthy volunteers. J Pharmacokinet Biopharm (1977) 0.85
Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailability. Antimicrob Agents Chemother (1992) 0.85
Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man. Br J Clin Pharmacol (1980) 0.84
Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer. Cancer Chemother Pharmacol (1999) 0.84
Haloperidol metabolism and antipsychotic effect in schizophrenia. Lancet (1987) 0.84
Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats. J Pharmacol Exp Ther (1982) 0.84
Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocking agents betaxolol (SL 75212) in healthy volunteers. Br J Clin Pharmacol (1980) 0.83
Plasma renin activity in depressed patients treated with increasing doses of lithium carbonate. Psychopharmacologia (1975) 0.83
[2-COM: presentation of an instrument facilitating communication between physicians and carers in daily practice]. Encephale (2007) 0.83
High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. Am J Psychiatry (1995) 0.83
A Kinetic Model for Simultaneous Fit of Clozapine and Norclozapine Concentrations in Chronic Schizophrenic Patients during Long-Term Treatment. Clin Drug Investig (1998) 0.82
Cardiovascular effects of single oral doses of the new beta-adrenoceptor blocker SL 75212 in healthy volunteers [proceedings]. Br J Clin Pharmacol (1979) 0.82
The blood pressure lowering effects of intravenous versus intracerebroventricular prazosin in anaesthetised cats. Eur J Pharmacol (1978) 0.82
Heterosexuals and HIV disease: a controlled investigation into the psychosocial factors associated with psychiatric morbidity. J Psychosom Res (1994) 0.82
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. Schizophr Res (1997) 0.81
Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients. Ther Drug Monit (2005) 0.81
Comparison of single-dose pharmacokinetics of imipramine and maprotiline in the elderly. Psychopharmacology (Berl) (1980) 0.81
Meal-dependent absorption of enteric-coated sodium valproate. Epilepsia (1980) 0.81
Model-based approach and signal detection theory to evaluate the performance of recruitment centers in clinical trials with antidepressant drugs. Clin Pharmacol Ther (2008) 0.81
Heart rate lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow. J Pharmacol Exp Ther (1981) 0.81
Comparison of mianserin with desipramine, maprotiline and phentolamine on cardiac presynaptic and vascular postsynaptic alpha-adrenoceptors and noradrenaline reuptake in pithed normotensive rats. Br J Pharmacol (1980) 0.81
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia. PLoS One (2012) 0.80
Pharmacokinetics and metabolism of diltiazem in man. Acta Cardiol (1980) 0.80
Degree of control of physician-diagnosed asthma and COPD in Italy. Monaldi Arch Chest Dis (2007) 0.80
Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia. Biol Psychiatry (1994) 0.80
Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients. J Psychopharmacol (2008) 0.80
Plasma concentrations and cardiotoxic effects of desipramine and protriptyline in the rat. Br J Pharmacol (1977) 0.80
Expression of alien H-2 specificities of a chemically induced BALB/c fibrosarcoma. Int J Cancer (1977) 0.80
Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone. J Pharmacol Exp Ther (1981) 0.80
Suicide attempts in schizophrenic patients: clinical variables. Asian J Psychiatr (2013) 0.80
Population pharmacokinetics of amikacin in critically ill patients. Antimicrob Agents Chemother (1996) 0.80
Plasma and brain pharmacokinetics of mianserin after single and multiple dosing in mice. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.79
Turnover of free and conjugated (sulphonyloxy) dihydroxyphenylacetic acid and homovanillic acid in rat striatum. J Neurochem (1979) 0.79
A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM. Eur J Clin Pharmacol (1996) 0.79
In vitro and in vivo expression of original and foreign H-2 antigens and of the tumor-associated transplantation antigen of a murine fibrosarcoma. Int J Cancer (1978) 0.79
Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline. Int Clin Psychopharmacol (1989) 0.79
Kinetics of distribution of di-propranolol in various organs and discrete brain areas of the rat. J Pharmacol Exp Ther (1980) 0.79
Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration. Arzneimittelforschung (1980) 0.79
The psychosocial impact of HIV infection in women. J Psychosom Res (1993) 0.79
Depression of cellular immune response during syngeneic pregnancy as measured by the graft-versus-host reaction. Transplantation (1975) 0.79
Predictive performance of a semiparametric method to estimate population pharmacokinetic parameters using NONMEM. J Pharmacokinet Biopharm (1998) 0.79
Alternative prophylactic treatments to lithium in bipolar disorders. Clin Neuropharmacol (1990) 0.79
[Echocardiographic monitoring of atrial septostomy in the transposition of the great arteries]. G Ital Cardiol (1984) 0.79
Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings]. Br J Clin Pharmacol (1979) 0.79
Quazepam versus triazolam in patients with sleep disorders: a double-blind study. Int J Clin Pharmacol Res (1993) 0.79
Mechanism of antihypertensive activity of orally administered prazosin in spontaneously hypertensive rats. J Cardiovasc Pharmacol (1980) 0.78
Effects of mianserin on noradrenaline uptake, cardiac presynaptic and vascular postsynaptic alpha-adrenoceptors in rats [proceedings]. Br J Pharmacol (1979) 0.78
[Study in man of butobarbital pharmacokinetics, under polygraphic monitoring]. Therapie (1978) 0.78